Abstract
Efficacy of vemurafenib (V), a selective <sup>V600E</sup>b-raf inhibitor, as monotherapy or in combination with erlotinib (Erl) or erbitux (Erb) and irinotecan (Iri) doublets and triplets in a colorectal cancer (CRC) xenograft model.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have